August 17 (UPI) – Stem mobile healing corporations in Israel and the United Arab Emirates signed an agreement Monday to collaborate on a possible remedy for COVID-19.
Both treat patients with COVID-19 with stem cells.
The Abu Dhabi Stem Cell Center has begun a treatment that sends blood-based stem cells back to the patient’s lungs like a thin mist from a nebulizer.
“We are incredibly proud to join with our ADSCC colleagues in sharing the wisdom and experience that we will advance health care within and outside our borders,” the CEO and President of Pluristem, Yaky Yanay, said in the statement.
“Pluristem is a major player in the mobile treatment box with years of experience, an exclusive platform and a physically powerful clinical portfolio,” Ventura said. “We are very happy to join forces and publicize the studies and progression of mobile treatments for the most productive patients and human society as a whole.”
The agreement is the time for a cross-border agreement since President Donald Trump negotiated an agreement to normalize between Israel and the United Arab Emirates. This follows a cross-border agreement on Sunday between EMIRATE-based APEX National Investment and Israel’s TeraGroup organization to conduct coronavirus research.